SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — John Locke

PatientJohn Locke
Date of birth1966-09-08
IdentifiersMRN HR-EN001-SYN; SSN (made up) 000-01-8305
Document date2026-10-08
AuthorPrudence Hartwell-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

A cold for three days, now with cough, wheeze, and a lower peak flow. [S]

History of Present Illness

Mr. Locke is a 60-year-old man with asthma and persistent airflow limitation on budesonide-formoterol maintenance and reliever therapy with tiotropium, who called this morning and was seen the same day. Three days ago he developed a sore throat and runny nose after a houseguest's cold; since yesterday he has had a cough, wheeze, and tightness, and woke twice last night. His home peak flow has been 290 to 310 L/min against a personal best of 440, the yellow zone of his action plan. Following the plan, he has taken five or six extra inhalations of budesonide-formoterol a day on top of his four maintenance inhalations, never more than 12 in a day, with relief for several hours each time. He has had a temperature of 37.6 C, no shaking chills, no chest pain, and no colored sputum. A home COVID-19 test yesterday was negative. He had this season's influenza, COVID-19, and RSV vaccines three weeks ago. [S]

ElementDetail
OnsetCold three days ago; chest symptoms since yesterday
SeverityHome peak flow 290 to 310 L/min (66 to 70 percent of best); woke twice last night
Treatment so farFive or six extra budesonide-formoterol inhalations a day, within 12 a day; tiotropium continued
Pertinent negativesNo high fever, chest pain, colored sputum, or breathlessness at rest; home COVID-19 test negative

Review of Systems

SystemResultFinding
ConstitutionalPositiveLow-grade temperature and tiredness; eating and drinking normally
Ears, nose, mouth, and throatPositiveSore throat and clear runny nose; no ear or facial pain
RespiratoryPositiveCough, wheeze, and chest tightness; no hemoptysis or pleuritic pain
CardiovascularNegativeNo chest pain, palpitations, or ankle swelling

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two puffs every 4 hours as needed while tests are done; hold for 6 hours before spirometryTwo puffs every 4 hours as neededRespiratory tract route2026-03-12 to 2026-03-26completedS
Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 4): two inhalations twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a dayTwo inhalations twice daily plus one as needed; no more than 12 a dayRespiratory tract route2026-03-26activeS
Tiotropium 2.5 mcg/actuation soft-mist inhaler, two inhalations once daily (add-on long-acting muscarinic antagonist, GINA step 5)Two inhalations once a dayRespiratory tract route2026-06-18activeS
Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for aches or fever, no more than 3 g a dayOne or two tablets every 6 hours as needed; no more than six tablets a dayOral route2026-10-08 to 2026-10-22completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-08Body height178cmS
2026-10-08Body weight62.6kgS
2026-10-08Body mass index (BMI) [Ratio]19.8kg/m2S
2026-10-08Systolic blood pressure124mm[Hg]S
2026-10-08Diastolic blood pressure76mm[Hg]S
2026-10-08Heart rate94/minS
2026-10-08Respiratory rate20/minS
2026-10-08Body temperature37.6CelS
2026-10-08Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-08Maximum expiratory gas flow Respiratory system airway by Peak flow meter300L/min80 percent of his personal best of 440 L/minLowS

Physical Exam

Vital signs recorded on 2026-10-08; see the Vital Signs section. [S]

SystemFinding
GeneralTired but comfortable; speaks in full sentences; no use of accessory muscles
Ears, nose, and throatClear nasal discharge; mild pharyngeal redness without exudate
RespiratoryScattered expiratory wheeze throughout both lungs; no crackles or bronchial breathing; respiratory rate 20; oxygen saturation 95 percent
CardiovascularHeart rate 94, regular; no edema

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic cough with wheeze and breathlessness since his late thirties, worse every winter and within a day of any stay in the city or by an open fire, better in warm weather and country air; night cough two or three times a week this winter; under evaluationresolvedconfirmed R05.3S — Synthetic presenting problem echoing his documented lifelong cough and breathlessness in London's coal smoke; superseded by the diagnosis at the second visit.
Long exposure to urban air pollution (decades in a large city with heavy traffic and coal and wood burning) and to indoor solid-fuel smoke from open coal and wood fires at homeactiveconfirmed Z77.110S — Synthetic modern exposure echoing the coal smoke that he, Sydenham, and Lady Masham blamed for his cough; no historical level of exposure is asserted.
Asthma with persistent airflow limitation, type 2 (eosinophilic) phenotype, in a never-smoker: post-bronchodilator FEV1/FVC 0.62, FEV1 62 percent predicted rising 380 mL after albuterol, FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, IgE 186 IU/mL, normal DLCO, no emphysema on CT; aggravated by air pollution and indoor smoke; not COPDactiveconfirmed J45.40S — Synthetic modern diagnosis. His lifelong cough and breathlessness worse in coal smoke are documented (D); calling them asthma is a modern retrospective reading (R).
Acute viral upper respiratory infection (common cold) with a yellow-zone asthma flare: peak flow 68 percent of personal best, managed with extra as-needed budesonide-formoterol by his action plan, without oral corticosteroids; resolvedactiveconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it echoes, without asserting, his documented autumn chest troubles (CLM-0014).

Assessment and Plan

Guideline basis: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016)

Follow-up: Asthma review in one week; sooner for the warning signs above. Next scheduled visit 2026-10-22: asthma review two weeks after a cold with a yellow-zone flare. [S]